Riconpharma Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RICONPHARMA LLC, and what generic and branded alternatives to RICONPHARMA LLC drugs are available?
RICONPHARMA LLC has seven approved drugs.
Drugs and US Patents for Riconpharma Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Riconpharma Llc | SCOPOLAMINE | scopolamine | SYSTEM;TRANSDERMAL | 212342-001 | Nov 24, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Riconpharma Llc | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216404-002 | Dec 2, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Riconpharma Llc | FLUNISOLIDE | flunisolide | SPRAY, METERED;NASAL | 207802-001 | Jun 16, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.